Translate

Saturday, May 8, 2021

Listen to the Scientist But Which Ones?- The Coming COVID Catastrophe

 The US Centers for Disease Control and Prevention said this week it had designated a coronavirus variant first seen in India as a "variant of interest," adding it to the growing collection of viral variants it's keeping an eye on.

Vaccine makers are so worried about the chance new variants will escape the protection offered by immunization that they are already testing booster shots and tweaking their vaccine formulas to specifically target some of the more troubling variants.
And doctors around the world are warning that even more variants will arise as the virus continues to evolve inside the bodies of the tens of millions of people it is infecting.

The Curious Case of Geert Vanden Bossche. by Rosemary Frei, MSc RosemaryFrei.ca. On March 6, an open letter by Geert Vanden Bossche, PhD, DVM, and a video interview of him by Phillip McMillan, MD, from a company called Vejon Health, were posted online. On the surface, Vanden Bossche appears to perhaps be addressing credible concerns about Covid.

 https://banned.video/watch?id=60963a001c422219d9d37710



   Vanden Bossche, Geert/ Curriculum Vitae Personal Name : Geert Vanden Bossche Residence: Ottenburg (Huldenberg), Belgium Nationality: Belgian/US resident and green card holder (granted since 13/7/2010 based on ‘advanced degrees and exceptional abilities’) Languages: Native Dutch, fluent English, French & German Education and Professional Training 1977-1980 UNIVERSITY OF NAMUR (FNDP), BE Faculty of Veterinary Medicine (cum laude) 1980-1983 UNIVERSITY OF GHENT (RUG), BE Graduated in Veterinary Medicine (cum laude) Doctoral Script (DVM): “Synthesis and Characterization of Monoclonal Antibodies against Bovine Rotavirus” 1996 UNIVERSITY OF HOHENHEIM/ STUTTGART, Germany Habilitation & venia legendi in Virology, Faculty of Agricultural Sciences Ph.D. Thesis: “Colloidal Aspects of Enteroviral Infectivity in Aqueous Environments” (i.e., exploring correlates between surfactant-triggered changes in surface properties of viral particles and their infectious behavior) 

 

 

No comments:

Post a Comment